200 related articles for article (PubMed ID: 16627043)
1. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
[TBL] [Abstract][Full Text] [Related]
2. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigão A; Souza MH; Mauck C; Waller D; Zaneveld L; Faúndes A
Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
[TBL] [Abstract][Full Text] [Related]
3. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S
Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
[TBL] [Abstract][Full Text] [Related]
4. Study of the intravaginal insert (IVI): acceptability, side effects, and post-coital spermicidal activity.
Ahmad M; Asch RH
Acta Eur Fertil; 1984; 15(5):369-76. PubMed ID: 6099026
[TBL] [Abstract][Full Text] [Related]
5. A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.
Mauck CK; Weiner DH; Creinin MD; Barnhart KT; Callahan MM; Bax R
Contraception; 2004 Sep; 70(3):233-40. PubMed ID: 15325893
[TBL] [Abstract][Full Text] [Related]
6. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
7. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.
Keller MJ; Carpenter CA; Lo Y; Einstein MH; Liu C; Fredricks DN; Herold BC
PLoS One; 2012; 7(10):e46901. PubMed ID: 23056520
[TBL] [Abstract][Full Text] [Related]
8. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
9. ACIDFORM: a review of the evidence.
Bayer LL; Jensen JT
Contraception; 2014 Jul; 90(1):11-8. PubMed ID: 24565736
[TBL] [Abstract][Full Text] [Related]
10. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
[TBL] [Abstract][Full Text] [Related]
11. Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).
Garg S; Anderson RA; Chany CJ; Waller DP; Diao XH; Vermani K; Zaneveld LJ
Contraception; 2001 Jul; 64(1):67-75. PubMed ID: 11535216
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of the new contraceptive sponge Protectaid.
Creatsas G; Elsheikh A; Colin P
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):91-5. PubMed ID: 12201327
[TBL] [Abstract][Full Text] [Related]
13. The effects of three nonoxynol-9 preparations on vaginal flora and epithelium.
Watts DH; Rabe L; Krohn MA; Aura J; Hillier SL
J Infect Dis; 1999 Aug; 180(2):426-37. PubMed ID: 10395859
[TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
Fichorova RN; Bajpai M; Chandra N; Hsiu JG; Spangler M; Ratnam V; Doncel GF
Biol Reprod; 2004 Sep; 71(3):761-9. PubMed ID: 15128598
[TBL] [Abstract][Full Text] [Related]
15. Microbicidal spermicide or spermicidal microbicide?
Gupta G
Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):212-8. PubMed ID: 16448947
[TBL] [Abstract][Full Text] [Related]
16. [A clinical study of the local contraceptive C-Film Lucchini].
Porozhanova V; Bozhinova S; Khristova V
Akush Ginekol (Sofiia); 1999; 38(3):54-6. PubMed ID: 10734685
[TBL] [Abstract][Full Text] [Related]
17. An overview of properties of Amphora (Acidform) contraceptive vaginal gel.
Nelson AL
Expert Opin Drug Saf; 2018 Sep; 17(9):935-943. PubMed ID: 30136907
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial.
Raymond EG; Chen PL; Luoto J;
Obstet Gynecol; 2004 Mar; 103(3):430-9. PubMed ID: 14990402
[TBL] [Abstract][Full Text] [Related]
19. Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners.
Trottier S; Omar RF; Désormeaux A; Drouin J; Gagnon MT; Vezina F; Guilbert E; Mâsse B; Bergeron MG
Contraception; 2007 Aug; 76(2):117-25. PubMed ID: 17656181
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States.
Mayer KH; Peipert J; Fleming T; Fullem A; Moench T; Cu-Uvin S; Bentley M; Chesney M; Rosenberg Z
Clin Infect Dis; 2001 Feb; 32(3):476-82. PubMed ID: 11170957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
